On the evening of December 10, 2015, in the blue and gold concert hall in Stockholm, an eighty-four-year-old Chinese woman in a dark suit walked across the stage to accept the Nobel Prize in Physiology or Medicine. Tu Youyou was, by the standards of Nobel laureates, an almost impossible figure. Chinese reporters called her the scientist of three nos: no doctorate, no training abroad, no seat in either of China’s national academies. She had spent her entire career inside one Beijing institute, much of it anonymous, and the work for which she was now being honoured had been done as a state secret during the Cultural Revolution, under a project so classified that she could not tell her husband what she did all day. The drug that came out of that project, artemisinin, and the therapies built upon it have since been deployed in the hundreds of millions of treatments and are credited with saving millions of lives, the largest single blow struck against malaria in the history of the disease. And the strangest part of the story, the part that still provokes argument ten years later, is where Tu found the idea: not in a journal, not in a military laboratory’s brainstorm, but in a seventeen-hundred-year-old emergency handbook written by a fourth-century alchemist, in a single sentence that everyone before her had read and misread.
The project had begun in war. By 1967 the conflict in Vietnam was at full pitch, and North Vietnam’s army was being destroyed less by American firepower than by a parasite. Malaria was disabling more of Hanoi’s soldiers than bombs were, resistant strains were shrugging off chloroquine, the standard drug of the era, and Ho Chi Minh’s government asked Beijing for help. On May 23, 1967, Zhou Enlai’s government convened a secret military research programme, known ever after by the date of its founding: Project 523. It grew to encompass more than five hundred scientists at some sixty institutions across China, soldiers and botanists and chemists mobilised against Plasmodium falciparum as if it were an invading army, which, in the jungles to the south, it effectively was. All of this unfolded as the Cultural Revolution convulsed Chinese science. Laboratories were smashed, senior researchers were sent to feed pigs in the countryside, universities closed. Yet 523 kept working, protected by its military seal, one of the few places in China where a competent young scientist could still do science.
Tu Youyou arrived in 1969, thirty-nine years old, a pharmacognosist from the Academy of Traditional Chinese Medicine, trained in both the old pharmacy and the new chemistry. Her assignment was to find candidate drugs, and her strategy was the one her institute existed to pursue: mine the archive. China possesses the largest written record of medical practice of any civilisation, an unbroken literature of case notes and formularies running back two thousand years, and Tu’s team combed it systematically. They surveyed more than two thousand traditional texts and folk manuals, extracted some 640 plausible prescriptions, and tested around 380 extracts drawn from about 200 herbs against malaria parasites in mice. The results were dismal. A few leads showed partial activity and then failed to reproduce. One of the most frustrating was qinghao, sweet wormwood, Artemisia annua, recommended by ancient sources against the intermittent fevers that were malaria’s signature. Sometimes an extract inhibited the parasite by two-thirds; more often it did almost nothing. By 1971 the wormwood thread looked as dead as every other.
What saved it was a verb. Going back over the sources one more time, Tu stopped at the oldest of them, the Handbook of Prescriptions for Emergencies, compiled around the year 340 by Ge Hong, a Daoist alchemist and physician of the Jin dynasty. Ge Hong’s instruction for qinghao was unlike the others, because it was not a decoction. He did not tell the physician to boil anything.
Take one handful of qinghao, soak it in two sheng of water, wring out the juice, and drink it all.
Wring out the juice. In a literature of boiling pots and simmering decoctions, here was a recipe with no fire in it. Tu’s question rearranged itself: what if heat was the enemy? If the active substance in the plant was being destroyed at the temperatures of a traditional decoction, then the ancient author had preserved, in his choice of verb, a piece of process knowledge that later generations had cooked away. The team redesigned the extraction around that single word, switching to ether at low temperatures, cold enough to spare whatever the plant was holding. On October 4, 1971, extract number 191, a low-temperature ether preparation of qinghao, was run against malaria-infected mice. The inhibition was one hundred per cent. It held in monkeys. After hundreds of failures, the archive had finally answered.
What happened next belongs to a different era’s research ethics, and to this story’s peculiar courage. Before the extract could go into patients, someone had to take it first, and in July 1972 Tu and two of her colleagues checked themselves into a hospital and swallowed it. It did them no harm. The clinical trial followed in August, in Hainan, the fever island off China’s south coast: twenty-one malaria patients, several carrying the chloroquine-resistant falciparum strain that was breaking the world’s pharmacopoeia. All twenty-one recovered. By 1973 the group had isolated the pure active crystals and named the compound qinghaosu, artemisinin; by 1975 Chinese chemists had solved its structure, a strange peroxide-bridged molecule unlike any antimalarial ever seen, and in 1977 the findings were published under a collective name, the Qinghaosu research group, no individual credited, in the manner of the time. Derivatives followed: artemether, artesunate, dihydroartemisinin, drugs more potent and more practical than the parent compound. The world, wrapped in Cold War suspicion and slow to trust Chinese data, took decades to catch up, but by the middle of the 2000s the World Health Organization had made artemisinin-based combination therapies the global first-line standard against falciparum malaria. They remain so today.
Stockholm, when it finally came, detonated an argument that has never quite settled. Traditional medicine’s champions claimed the Nobel as vindication: the ancients had known, and the moderns had merely confirmed. Its critics claimed the opposite: artemisinin is a single purified molecule, dosed by milligram, the fruit of ether and chromatography, and the thousands of unproven remedies that failed Tu’s screens stand as the archive’s true report card. Tu herself refused both simplicities, and her Nobel lecture’s title became the story’s summary line: artemisinin was, she said, a gift from traditional Chinese medicine to the world. The archive had not been the answer; it had been the filter. When Western programmes had screened plants at random, they had drowned in hundreds of thousands of candidates. Tu’s team had searched two hundred, chosen by people who had watched fevers for two millennia and written down what they saw. The filter even preserved the manufacturing instruction, in the choice of a verb. The chemistry did the rest. Both things were true, and the Nobel, pointedly, was for the synthesis.
Inside China, the prize landed with a second, quieter charge. The scientist of three nos had done the greatest work of Chinese science in the modern era, and the system that produced academicians had never found a seat for her. The commentary wrote itself: editorials asked what the academies were measuring, if this was what they missed, and young researchers repeated the three nos as a kind of talisman against credentialism. There was a deeper irony underneath. The discovery had been made possible by a state mobilisation of the old type, five hundred people and a military seal, yet its decisive moment had been one woman, one sentence, one verb, read correctly at the right hour. China had spent the twentieth century arguing about whether its future lay in the collective or the individual, the archive or the laboratory, and the answer turned out to be a secret project that succeeded because a single reader refused to skim.
To grasp how unlikely that synthesis was, it helps to know the scale and age of the archive she mined. Chinese medicine begins, like so much else Chinese, in the mythical deep past, with Shennong, the Divine Farmer, the same culture-hero credited with teaching humanity agriculture, who is said to have tasted hundreds of herbs in a single day to learn their properties, surviving, the legend adds, seventy poisonings. The herbal tradition that bears his name, the Shennong Benjing, was compiled in the Han dynasty, and it ranks its drugs with a bureaucrat’s instinct: superior drugs that nourish life, middling drugs that nourish the constitution, inferior drugs that attack disease and must be handled with care. Even the legend encodes the tradition’s temperament. Medicine, in this civilisation, was record-keeping from the start.
The theory arrived with the Yellow Emperor, whose shadow has fallen across this series before. The Huangdi Neijing, the Inner Canon, compiled by the second century BC as a dialogue between the emperor and his physician Qi Bo, founded the conceptual system that Chinese medicine still speaks: qi as the body’s motivating breath, yin and yang as its accounts ledger, the five phases as its ministries. The metaphor at the canon’s heart is administrative. The heart rules like a sovereign, the liver commands like a general, the spleen manages like a granary official, and disease is a failure of government, rebellion or blockade in the body’s provinces. A state that understood itself as an organism produced, naturally enough, a medicine that understood the organism as a state.
The tradition’s working genius was Zhang Zhongjing, a Han dynasty prefect who watched an epidemic carry off two-thirds of his own clan in a decade and answered it with the Treatise on Cold Damage, completed around the year 210. Zhang’s revolution was procedural: he organised treatment around patterns, constellations of signs that told the physician which of his formulas to deploy, and his book became the closest thing Chinese medicine has to an operating manual. It has never gone out of print. His formulas are prescribed in China today, manufactured as granules, and industrialised in Japan under the name kampo, where they sit inside the national health system beside modern drugs. An eighteen-hundred-year-old formulary with market share: there is nothing comparable in the Western tradition.
Ge Hong, the author of Tu’s crucial sentence, was one of the tradition’s most interesting figures, and the handbook was not his masterwork but his pocketbook. He was an alchemist of the Daoist school, author of the Baopuzi, a grand treatise on the pursuit of immortality, and his emergency manual was written for travellers and the poor, remedies that were cheap, available, and quick. It shows. The little book contains the first clear description of smallpox in any literature, distinguishing it from other eruptive fevers, and an eerily accurate account of scrub typhus carried by mites. His wife, Bao Gu, practised moxibustion beside him and survives in the record as one of the first named female practitioners in Chinese medicine. The sentence that would one day redirect malaria research sat for sixteen centuries in a book whose entire premise was that useful knowledge should be cheap enough to carry and plain enough to use. Tu’s genius was to take the little book at its word.
The tradition’s conscience was Sun Simiao, the Tang dynasty physician remembered as the King of Medicine, who died in 682 at an age the records give as past one hundred and legend inflates to one hundred and forty-one. His collection of Prescriptions Worth a Thousand Pieces of Gold opens with an essay that medical students in China still read, On the Absolute Sincerity of Great Physicians, and its demand is uncompromising: the physician must treat rich and poor, noble and lowly, old and young, friend and stranger, Chinese and barbarian, all alike, must not consider his own comfort or his own fortune, must regard the patient’s suffering as his own. It reads like the Hippocratic oath rewritten with more heart, a thousand years before the West professionalised its ethics.
And the tradition’s monument is Li Shizhen’s Compendium of Materia Medica, the Bencao Gangmu. Li was a sixteenth-century physician from Hubei who spent twenty-seven years, three complete rewrites, and the labour of his sons compiling everything the archive knew about the substances of the world: 1,892 drugs, plant, animal, and mineral, with some eleven thousand prescriptions, in fifty-two volumes, published in 1596, three years after his death. He corrected his predecessors’ errors herb by herb, tested what he could test, and organised the whole by a natural classification of his own devising. The book became the standard reference across East Asia, and when Charles Darwin, three centuries later, assembled evidence on variation under domestication, he cited a great Chinese encyclopaedia of natural knowledge that scholars identify as Li’s compendium. The archive, it turns out, had readers everywhere.
One more gift of that archive deserves its own paragraph, because it changed the world as profoundly as artemisinin and is even less known: China invented inoculation. By the sixteenth century at the latest, and by tradition much earlier, Chinese physicians were practising variolation against smallpox, taking powdered scabs from a mild case and blowing the powder up the healthy patient’s nostril, producing a controlled, survivable infection that conferred lifetime immunity. The method killed perhaps one patient in a hundred, against the disease’s natural toll of one in three, and the Qing court adopted it so thoroughly that the Kangxi emperor had his children and his banner troops inoculated. The practice travelled west along the Silk Road and through the Ottoman world, where Lady Mary Wortley Montagu saw it in Constantinople and carried it home to London in 1718, whence it spread through Europe as the first deliberate immunisation in Western medicine. When Edward Jenner introduced vaccination with cowpox in 1796, he was improving a Chinese idea by then two centuries old. The entire science of immunisation, the technology that has saved more lives than any other in medical history, descends from a Chinese physician’s sniff of powder.
The tradition’s other great export took the opposite route, through a newspaper column. In July 1971, as Henry Kissinger was secretly arranging the American opening to Beijing, the New York Times columnist James Reston fell ill in the Chinese capital with appendicitis, and his post-operative pain was treated, at his doctors’ suggestion, with acupuncture. His front-page account of needles and smouldering herbs in a Beijing hospital, published while the world was still adjusting to the idea of a visitable China, set off a fascination in the West that has never fully subsided. Within a decade acupuncture had practitioners on every continent; within two, professional bodies and hospital pain clinics had absorbed it; today the World Health Organization counts traditional medicine users in the billions and member states regulating its practice in the scores. The needles travelled better than the theory ever did. What the West took was the technique, stripped of qi and meridians and re-examined trial by trial, and the result is another parable of the archive and the assay: a practice carried across the world on a columnist’s deadline, then ground down to whatever the evidence could hold.
Where does that leave the tradition today? In a strange, doubled position, which the artemisinin argument never resolved. The Chinese state promotes traditional medicine as heritage and as industry: a dedicated law took effect in 2017, the World Health Organization admitted a traditional-medicine chapter into its global disease classification in 2019, and the sector’s output is officially measured in the trillions of yuan, a pillar of the healthcare economy. During the pandemic years, herbal formulations were distributed by the million and argued over accordingly. Meanwhile the assay keeps its own counsel, confirming some of the archive, discarding more, and asking, always, for the extract, the milligrams, the trial. Tu Youyou’s career stands between the two camps as the demonstration of what each is for. The archive is not a pharmacy; it is a map of two thousand years of clinical observation, drawn by people who had no microscopes and infinite patience. The laboratory is not a refutation of the map; it is the instrument that tells you where on the map the gold lies.
That is the reading this series has learned to expect from China: the long maintenance of the record, the patient accumulation across dynasties, and then, at the appointed hour, the synthesis. Ge Hong wrote his sentence around the year 340 for a traveller with a fever and no money. It waited through sixteen centuries of dynasties, through the fall of the Jin and the Tang and the Ming, through the closing of the laboratories and the smashing of the institutes, until a thirty-nine-year-old pharmacognosist with three nos to her name read the verb correctly. The gift, when it was finally unwrapped in Stockholm, had been in the post since the fourth century.
